Impaired clearance of oxidised proteins in neurodegenerative diseases
暂无分享，去创建一个
[1] A. Rapkin,et al. Progesterone Metabolite Allopregnanolone in Women With Premenstrual Syndrome , 1997, Obstetrics and gynecology.
[2] S. Berga,et al. Blunted Phase-Shift Responses to Morning Bright Light in Premenstrual Dysphoric Disorder , 1997, Journal of biological rhythms.
[3] W. Markesbery,et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[4] E. Baulieu. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. , 1997, Recent progress in hormone research.
[5] B. E. Collins,et al. Brain neurosteroids during the mouse oestrous cycle , 1997, Brain Research.
[6] K. Davies,et al. Breakdown of oxidized proteins as a part of secondary antioxidant defenses in mammalian cells , 1997, BioFactors.
[7] A. Lees,et al. A Generalised Increase in Protein Carbonyls in the Brain in Parkinson's but Not Incidental Lewy Body Disease , 1997, Journal of neurochemistry.
[8] M. Larkin. Therapeutic target reveals itself in diseased neurons , 1998, The Lancet.